| Literature DB >> 30219082 |
Mine Turgut1, Vedat Cinar1, Ragip Pala1, Mehmet Tuzcu2, Cemal Orhan3, Hafize Telceken3, Nurhan Sahin3, Patrick Brice Defo Deeh4, James R Komorowski5, Kazim Sahin6.
Abstract
BACKGROUND: Chromium histidinate (CrHis) and biotin are micronutrients commonly used to improve health by athletes and control glycaemia by patients with diabetes. This study investigates the effects of 8-week regular exercise training in rats together with dietary CrHis and biotin supplementation on glucose, lipids and transaminases levels, as well as protein expression levels of peroxisome proliferator-activated receptor gamma (PPAR-γ), insulin receptor substrate-1 (IRS-1) and nuclear transcription factor kappa B (NF-κB).Entities:
Keywords: Biotin; Chromium Histidinate; IRS-1; NF-κB; PPAR-γ
Mesh:
Substances:
Year: 2018 PMID: 30219082 PMCID: PMC6139124 DOI: 10.1186/s12970-018-0249-4
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Effects of chromium histidinate and biotin on body weight, Cr and biotin intake and serum parameters in exercise-trained rats
| Parameters | C | CrHis | Bio | CrHis+Bio | E | E + CrHis | E + Bio | E + Bio + CrHis |
|---|---|---|---|---|---|---|---|---|
| Final body weight, g | 312.29 ± 4.33a | 301.86 ± 2.47a | 307.00 ± 4.20a | 301.43 ± 6.01a | 282.29 ± 2.62b | 270.86 ± 2.48b | 276.71 ± 4.93b | 273.29 ± 3.23b |
| Cr intake, μg/rat/day | 23.52 ± 1.15d | 32.45 ± 2.07b | 24.64 ± 1.83c | 32.43 ± 2.30b | 25.76 ± 1.46c | 35.4 ± 2.33a | 26.88 ± 2.91c | 36.88 ± 3.15a |
| Biotin intake, μg/rat/day | 5.46 ± 0.82c | 5.72 ± 0.75c | 135.3 ± 4.26b | 135.1 ± 3.85b | 5.98 ± 0.68c | 6.24 ± 1.33c | 147.5 ± 6.55a | 153.75 ± 8.70a |
| Glucose, mg/dL | 121.50 ± 3.53a | 110.71 ± 1.67b | 118.67 ± 1.48b | 106.86 ± 1.03c | 112.29 ± 2.67b | 97.71 ± 1.95d | 109.29 ± 1.51b | 93.57 ± 1.25e |
| Cholesterol, mg/dl | 86.72 ± 3.23a | 78.25 ± 2.61b | 80.55 ± 3.42b | 75.15 ± 3.20c | 77.43 ± 1.95b | 71.86 ± 2.35d | 76.99 ± 2.83b | 67.55 ± 2.85e |
| HDL, mg/dL | 11.48 ± 0.44d | 14.29 ± 0.42c | 13.32 ± 0.42cd | 15.86 ± 0.63c | 15.29 ± 0.78c | 18.14 ± 0.55b | 16.14 ± 0.59c | 22.71 ± 1.43a |
| Triglyceride, mg/dL | 139.00 ± 9.84a | 91.57 ± 4.85c | 108.67 ± 5.74b | 77.00 ± 5.23d | 68.43 ± 3.05e | 61.14 ± 2.82ef | 65.71 ± 6.28e | 51.71 ± 4.45g |
| AST, U/L | 245.67 ± 44.12 | 240.71 ± 16.38 | 239.00 ± 20.12 | 237.29 ± 17.02 | 239.71 ± 15.48 | 243.71 ± 19.67 | 242.43 ± 11.29 | 236.43 ± 21.01 |
| ALT, U/L | 102.00 ± 3.39 | 100.71 ± 4.32 | 103.17 ± 7.12 | 104.57 ± 4.45 | 106.29 ± 5.36 | 103.14 ± 2.76 | 105.29 ± 4.55 | 103.29 ± 3.90 |
Data are given as mean ± standard error. (a-g) The difference between the groups with different letters is statistically significant (p < 0.05). C Control, CrHis Chromium histidinate, Bio Biotin, E Exercise, HDL High-Density Lipoprotein, AST Aspartate aminotransferase, ALT Alanine aminotransferase
Primer sequences of genes used for real-time polymerase chain reaction
| Gene | Primer | Sequence |
|---|---|---|
| IRS-1 | Forward | 5′-GCGCAGGCACCATCTCAACAACC-3′ |
| Reverse | 5′-GCACGCACCCGGAAGGAACC-3′ | |
| PPAR-γ | Forward | 5′-TCAAACCCTTTACCACGGTT-3′ |
| Reverse | 5′-CAGGCTCTACTTTGATCGCA-3′ | |
| NF-κB | Forward | 5′-TGAGGCTGTTTGGTT TGAGA −3′ |
| Reverse | 5′-TTATGGCTGAGGTCTGGTCTG-3′ | |
| GAPDH | Forward | 5′-TGATGACATCAAGAAGGTGGTGAAG-3′ |
| Reverse | 5′TCCTTGGAGGCCATGTGGGCCAT-3′ |
IRS-1 insulin receptor substrate-1, PPAR-γ peroxisome proliferator-activated receptor gamma,
NF-κB nuclear factor kappa B
Fig. 1Effects of chromium histidinate and biotin supplementation on the expressions of IRS-1 (Panel a), PPAR-γ (Panel b) and NF-κB (Panel c) in the liver of sedentary and exercise-trained rats. Different superscripts (a–e) indicate group mean differences (p < 0.05)
Fig. 2Effects of chromium histidinate and biotin supplementation on the expressions of IRS-1 (Panel a), PPAR-γ (Panel b) and NF-κB (Panel c) in the muscle of sedentary and exercise-trained rats. Different superscripts (a–e) indicate group mean differences (p < 0.05)
Pearson’s correlation coefficients (r) among variable
| HDL | Triglyceride | AST | ALT | Liver IRS | Liver PPARγ | Liver NF-κB | Muscle IRS | Muscle PPARγ | Muscle NF-κB | |
|---|---|---|---|---|---|---|---|---|---|---|
| Glucose | − 0,746** | 0,732** | 0,045 | 0,018 | −0,852** | −0,878** | 0,904** | −0,854** | − 0,869** | 0,904** |
| HDL | −0,626** | −0,138 | − 0,049 | 0,855** | 0,849** | −0,881** | 0,809** | 0,817** | −0,881** | |
| Triglyceride | −0,088 | −0,095 | − 0,797** | −0,782** | 0,750** | −0,790** | − 0,774** | 0,750** | ||
| AST | 0,176 | 0,290 | 0,253 | −0,280 | 0,321 | 0,270 | −0,280 | |||
| ALT | 0,265 | 0,246 | −0,242 | 0,195 | 0,266 | −0,242 | ||||
| Liver IRS | 0,955** | −0,953** | 0,970** | 0,960** | −0,953** | |||||
| Liver PPARγ | −0,955** | 0,965** | 0,984** | −0,955** | ||||||
| Liver NF-κB | −0,946** | − 0,956** | 0,999** | |||||||
| Muscle IRS | 0,972** | −0,946** | ||||||||
| Muscle PPARγ | −0,956** |
HDL: High-Density Lipoprotein, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase. PPAR-γ: peroxisome proliferator-activated receptor gamma, IRS-1: insulin receptor substrate-1, NF-κB: nuclear transcription factor kappa B
** Correlation is significant at the 0.01 level.